ANPEP and Kaposi's sarcoma: Moreover, the biological activity of the compounds was also evaluated using both CD13(+) KS (Kaposi’s Sarcoma) cells and CD13(−) (but integrin receptor positive) HT-29 human colon adenocarcinoma cells [58].